View drug registration information details.
Items | Registration information |
ID | 1106 |
No | 1106 |
Brand Name | DEFERASIROX GPO |
Ingredients | DEFERASIROX 250 MG |
Dosage Form | DISPERSIBLE TABLET |
Primary Packaging | NYLON/ALU/PVC BLISTER |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 3 X 10'S |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | TREATMENT OF CHRONIC IRON OVERLOAD DUE TO BLOOD TRANSFUSIONS IN ADULT AND PEDIATRIC PATIENTS (AGED 2 YEARS AND OVER). ALSO INDICATED FOR THE TREATMENT OF CHRONIC IRON OVERLOAD IN PATIENTS WITH NONTRANSFUSION-DEPENDENT THALASSEMIA SYNDROMS AGED 10 YEARS AND OLDER |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | OFF WHITE, FLATE, ROUND, COMPRESSED TABLETS, ONE SIDE DEBOSEED WITH "D250" AND THE OTHER SIDE DEBOSSED WITH "GPO" |
Note | |
License Owner | KARNYA VIENGNAKORN EXPORT-IMPORT |
Manufacturer | THE GOVERNMENT PHARMACEUTICAL ORGANISATION |
Country | THAILAND |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 12 I 5163/21 |
FDD Registration Date | 10-SEP-2024 |
Expiry Date | 09-SEP-2029 |
Back to drug list
|